Cat. No. 2842
Biological ActivitySomatostatin sst5 receptor agonist (Ki values are 7.3, 13.5, 31.3 and 141 nM for sst5, sst2, sst1 and sst4 receptors respectively). Stimulates gastric emptying following i.c. administration.
(Modifications: Phe-1 = D-Phe, Trp-4 = D-Trp, Thr-8 = C-terminal amide)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
Nunn et al (2002) Pharmacological characterisation of the goldfish somatostatin sst5 receptor. Eur.J.Pharmacol. 436 173. PMID: 11858797.
Martinez et al (2000) Intracisternal injection of somatostatin receptor 5-preferring agonists induces a vagal cholinergic stimulation of gastric emptying in rats. J.Pharmacol.Exp.Ther. 293 1099. PMID: 10869415.
Patel and Srikant (1994) Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology 135 2814. PMID: 7988476.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses BIM 23052 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: BIM 23052, supplier, sst5, agonists, Receptors, Somatostatin, BIM23052, Tocris Bioscience, Somatostatin (sst) Receptor Agonist products
Find multiple products by catalog number
New Products in this Area
Non-peptide apelin receptor agonistBML 111
FPR2 (lipoxin A4 receptor) agonistAmylin (rat)
Potent endogenous peptide agonist for amylin, calcitonin, CGRP and adrenomedullin receptorsCalcitonin (human)
Endogenous calcitonin receptor agonist; inhibits bone resorptionSpexin
Potent GAL2/3 agonist; exhibits anxiolytic effects in vivoMM 54
Potent apelin receptor antagonist
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.